CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 1,923 shares at $6.75 ($12,980)
- 4 Open-market buy President and CEO bought 5,000 shares at $6.76 ($33,807)
- 4 Open-market buy President and CEO bought 2,500 shares at $8.58 ($21,438)
- 4 Open-market buy Director bought 250,000 shares at $8.00 ($2,000,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 2,500 shares at $4.34 ($10,850)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 50,000 shares at $3.98 ($199,000)
- 4 Open-market buy President and CEO bought 10,000 shares at $4.01 ($40,100)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 17 · 329 filings